Truist Financial Increases HCA Healthcare (NYSE:HCA) Price Target to $390.00

HCA Healthcare (NYSE:HCA) had its target price boosted by Truist Financial from $375.00 to $390.00 in a research note issued to investors on Wednesday, Benzinga reports. The firm currently has a “buy” rating on the stock. Truist Financial’s price objective indicates a potential upside of 10.55% from the company’s current price.

Other research analysts have also recently issued research reports about the stock. Barclays lifted their target price on shares of HCA Healthcare from $367.00 to $376.00 and gave the company an “overweight” rating in a research note on Wednesday, July 10th. Oppenheimer boosted their price target on shares of HCA Healthcare from $330.00 to $345.00 and gave the stock an “outperform” rating in a research note on Monday, April 29th. Deutsche Bank Aktiengesellschaft upped their target price on shares of HCA Healthcare from $359.00 to $375.00 and gave the company a “buy” rating in a research report on Friday, June 28th. Baird R W upgraded shares of HCA Healthcare to a “strong-buy” rating in a report on Thursday, May 30th. Finally, Wells Fargo & Company upped their price target on shares of HCA Healthcare from $303.00 to $315.00 and gave the company an “equal weight” rating in a report on Thursday, March 28th. Four equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $339.72.

HCA Healthcare Trading Up 2.6 %

Shares of HCA stock opened at $352.79 on Wednesday. HCA Healthcare has a 1 year low of $215.96 and a 1 year high of $356.30. The firm has a fifty day moving average price of $329.48 and a 200-day moving average price of $322.74. The company has a debt-to-equity ratio of 29.26, a current ratio of 1.16 and a quick ratio of 1.02. The company has a market cap of $92.40 billion, a price-to-earnings ratio of 17.59, a PEG ratio of 1.45 and a beta of 1.68.

HCA Healthcare (NYSE:HCA) last released its earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, beating analysts’ consensus estimates of $4.97 by $0.53. HCA Healthcare had a net margin of 8.40% and a return on equity of 621.57%. The company had revenue of $17.49 billion for the quarter, compared to analysts’ expectations of $17.05 billion. During the same quarter in the previous year, the company earned $4.29 EPS. HCA Healthcare’s revenue for the quarter was up 10.3% on a year-over-year basis. As a group, equities analysts predict that HCA Healthcare will post 22.2 earnings per share for the current year.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,863 shares of the firm’s stock in a transaction on Wednesday, May 15th. The shares were sold at an average price of $326.18, for a total value of $607,673.34. Following the completion of the transaction, the senior vice president now owns 19,612 shares of the company’s stock, valued at $6,397,042.16. The transaction was disclosed in a filing with the SEC, which is available at this link. In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,863 shares of the firm’s stock in a transaction on Wednesday, May 15th. The shares were sold at an average price of $326.18, for a total value of $607,673.34. Following the completion of the transaction, the senior vice president now owns 19,612 shares of the company’s stock, valued at $6,397,042.16. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, EVP Michael S. Cuffe sold 6,311 shares of the firm’s stock in a transaction on Thursday, May 9th. The stock was sold at an average price of $316.88, for a total transaction of $1,999,829.68. Following the completion of the transaction, the executive vice president now directly owns 29,624 shares of the company’s stock, valued at approximately $9,387,253.12. The disclosure for this sale can be found here. Insiders sold 12,397 shares of company stock valued at $3,921,929 over the last 90 days. Insiders own 1.60% of the company’s stock.

Institutional Trading of HCA Healthcare

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Parkside Financial Bank & Trust increased its stake in shares of HCA Healthcare by 8.2% in the fourth quarter. Parkside Financial Bank & Trust now owns 461 shares of the company’s stock worth $125,000 after acquiring an additional 35 shares during the period. FinTrust Capital Advisors LLC grew its position in HCA Healthcare by 26.7% during the fourth quarter. FinTrust Capital Advisors LLC now owns 166 shares of the company’s stock valued at $45,000 after buying an additional 35 shares during the period. Financial Counselors Inc. grew its position in HCA Healthcare by 1.4% during the first quarter. Financial Counselors Inc. now owns 2,642 shares of the company’s stock valued at $881,000 after buying an additional 36 shares during the period. Premier Path Wealth Partners LLC grew its position in HCA Healthcare by 2.7% during the second quarter. Premier Path Wealth Partners LLC now owns 1,393 shares of the company’s stock valued at $448,000 after buying an additional 36 shares during the period. Finally, Westside Investment Management Inc. grew its position in HCA Healthcare by 14.7% during the second quarter. Westside Investment Management Inc. now owns 289 shares of the company’s stock valued at $93,000 after buying an additional 37 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.